QS Batterymarch Financial Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

QS Batterymarch Financial Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$331K	Sell	2,058 -6,602	-76%	-$1.02M	0.01%	623
2014 Q2	$1.27M	Sell	8,660 -13,000	-60%	-$1.8M	0.03%	493
2014 Q1	$3M	Sell	21,660 -54,500	-72%	-$8.2M	0.06%	413
2013 Q4	$9.64M	Sell	76,160 -3,100	-4%	-$321K	0.2%	144
2013 Q3	$7.29M	Buy	79,260 +12,060	+18%	+$973K	0.16%	194
2013 Q2	$4.62M	Buy	+67,200	New	+$4.11M	0.09%	345

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

QS Batterymarch Financial Management's JAZZ Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 76% in Q3 2014, selling an estimated $1.02M and leaving 2,058 shares worth $331K. The position accounts for 0.01% of the portfolio, ranked #623.

QS Batterymarch Financial Management first reported a position in JAZZ in Q2 2013 and has held it in 6 quarters since. The position peaked at $9.64M in Q4 2013. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2014.

QS Batterymarch Financial Management held 2,058 shares of Jazz Pharmaceuticals worth $331K as of Q3 2014.
QS Batterymarch Financial Management sold 6,602 Jazz Pharmaceuticals shares in Q3 2014, an estimated $1.02M.
Jazz Pharmaceuticals made up 0.01% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #623 holding.
QS Batterymarch Financial Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
QS Batterymarch Financial Management's Jazz Pharmaceuticals position peaked at $9.64M in Q4 2013.
325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.